A topical cream formulation of the JAK inhibitor ruxolitinib was

allmyfamilycare.com
A topical cream formulation of the JAK inhibitor ruxolitinib was
The acute shortage of hematologists in Sub-Saharan Africa has given
Pfizer scientists are studying whether a THIRD vaccine shot can
Data-driven technologies can exacerbate existing health inequalities, according to a
The artificial intelligence-driven research firm BERG announced this week that
The COVID-19 crisis has accelerated innovation throughout much of the
TOKYO — September 23, 2020 FUJIFILM Toyama Chemical Co., Ltd.
Improving the prediction of survival indicators in patients with breast
Wolters Kluwer Health and Nuance Communications have joined forces to
Researchers from New York-based Mount Sinai Health System have combined